Cigna Current Deferred Revenue from 2010 to 2026
| CI Stock | USD 291.44 3.83 1.33% |
Current Deferred Revenue | First Reported 2010-12-31 | Previous Quarter -22.1 B | Current Value -21 B | Quarterly Volatility 13.4 B |
Check Cigna Corp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cigna Corp's main balance sheet or income statement drivers, such as Interest Expense of 1.5 B, Other Operating Expenses of 279.1 B or Operating Income of 9.6 B, as well as many indicators such as Price To Sales Ratio of 0.48, Dividend Yield of 0.0224 or PTB Ratio of 1.43. Cigna financial statements analysis is a perfect complement when working with Cigna Corp Valuation or Volatility modules.
Cigna | Current Deferred Revenue | Build AI portfolio with Cigna Stock |
The Current Deferred Revenue trend for Cigna Corp offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Cigna Corp is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Cigna Corp's Current Deferred Revenue Growth Pattern
Below is the plot of the Current Deferred Revenue of Cigna Corp over the last few years. It is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. Cigna Corp's Current Deferred Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cigna Corp's overall financial position and show how it may be relating to other accounts over time.
| Current Deferred Revenue | 10 Years Trend |
|
Current Deferred Revenue |
| Timeline |
Cigna Current Deferred Revenue Regression Statistics
| Arithmetic Mean | (12,029,080,588) | |
| Geometric Mean | 9,712,524,921 | |
| Coefficient Of Variation | (111.43) | |
| Mean Deviation | 12,574,546,436 | |
| Median | (21,010,770,000) | |
| Standard Deviation | 13,404,484,436 | |
| Sample Variance | 179680203T | |
| Range | 27.7B | |
| R-Value | (0.87) | |
| Mean Square Error | 48227649.7T | |
| R-Squared | 0.75 | |
| Slope | (2,296,346,471) | |
| Total Sum of Squares | 2874883248T |
Cigna Current Deferred Revenue History
About Cigna Corp Financial Statements
Investors use fundamental indicators, such as Cigna Corp's Current Deferred Revenue, to determine how well the company is positioned to perform in the future. Although Cigna Corp's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | -22.1 B | -21 B |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out the analysis of Cigna Corp Correlation against competitors. For more detail on how to invest in Cigna Stock please use our How to Invest in Cigna Corp guide.You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Is there potential for Health Care Providers & Services market expansion? Will Cigna introduce new products? Factors like these will boost the valuation of Cigna Corp. Projected growth potential of Cigna fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Cigna Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.11) | Dividend Share 6.04 | Earnings Share 22.18 | Revenue Per Share | Quarterly Revenue Growth 0.104 |
Cigna Corp's market price often diverges from its book value, the accounting figure shown on Cigna's balance sheet. Smart investors calculate Cigna Corp's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since Cigna Corp's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Cigna Corp's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cigna Corp should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Cigna Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.